Overall rank by patents
#6,036
of 50,000 tracked assignees
USPTO PatentsView assignee record - 56 granted patents across 18 technology areas, recorded in grant years 2015–2025. Grant-trend analysis is cross-referenced to USPTO Patent Public Search; it does not measure application filings, current R&D, or legal strength. Primary class: A61M (DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY ; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY ; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR).
The verdict
According to USPTO PatentsView, Intersurgical ranks #6,036 of 50,000 tracked US assignees by granted-patent volume, with 56 patents across 18 technology areas.
USPTO PatentsView assignee plate
Corpus R6036 · Foreign Corporation #6,036 · 56 grants
GRANTS-SMALL · UPPER-Q · PHOTO-FINISH · CPC-FOCUS · INNOV-THIN · CLAIMS-SPARSE · TYPE-FRNCORP · VEL-DOWN · BOOK-FULL
Nearest grant-volume peer: Global Blood Therapeutics, Inc. (±0 grants)
Instrument codes from this assignee’s USPTO PatentsView grant sheet: volume band, corpus rank, photo-finish peer, lead CPC, Innovation Score, claim depth, assignee type, velocity, and book completeness. Not a USPTO rating of patent strength.
Lowest and highest poles plus nearest Innovation Score peers, not a full corpus board reprint.
Qualcomm Incorporated · highest
85 score
Emisshield · near
36 score
Intersurgical · this assignee
36 score
Lutonix · near
36 score
Mitsubishi Heavy Ind… · near
36 score
Silk Road Medical · near
36 score
3D Lighting Innovati… · lowest
7 score
What this shows Intersurgical Ag stamps GRANTS-SMALL, UPPER-Q, PHOTO-FINISH, CPC-FOCUS, INNOV-THIN, CLAIMS-SPARSE, TYPE-FRNCORP, VEL-DOWN, BOOK-FULL. Volume places it #6,036 of 50,000; Innovation Score 36.1/100 sits in the top 47% of the PatentsView-derived corpus. Closest grant-volume peer on this plate is Global Blood Therapeutics, Inc. (±0 grants).
Intersurgical Ag has been granted 56 US utility patents between 2015 and 2025, placing Intersurgical Ag at #6,036 of 50,000 across all assignees tracked by PlainPatent. This portfolio spans 18 distinct Cooperative Patent Classification (CPC) subclasses, averaging 7.9 claims per patent with primary concentration in A61M (DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY ; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY ; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR). As a Foreign Corporation, Intersurgical Ag is one of the more focused assignees in the PatentsView dataset. By volume, Intersurgical sits between Global Blood Therapeutics, Inc. (56 patents, rank #6,031) and Johnson Controls Fire Protection Lp (56 patents, rank #6,039) - the closest US assignees by grant volume. The composite Innovation Score of 36.1/100 blends portfolio volume, grant velocity, technology breadth, and claim depth into a single comparable measure drawn directly from USPTO PatentsView records.
Grant cadence records the difference between two grant-year windows. Between 2020 and 2024 the company received 22 grants, compared with 32 in the 2015–2019 window, a -31% shift in five-year grant velocity. Both windows cover five complete grant years; the latest PatentsView year is a partial release and is excluded from this comparison, though it still appears in the yearly table and chart below. Grant timing can lag the related application by years, so this comparison does not establish current R&D spending, strategic intent, or a company’s application activity. The Foreign Corporation classification provides context for the assignee record, not a conclusion about its business strategy.
Claim depth and technology breadth describe this aggregate record. Intersurgical Ag's 7.9 average claims per patent is an average count, not a measure of claim scope, legal strength, enforceability, or design-around risk. The record spans 18 CPC subclasses. Combined with portfolio volume, these figures let readers compare the documented grant records of assignees in similar technology classes.
Granted US patents 2015–2025 versus its nearest-ranked assignees by volume, this company marked ◀
Global Blood Therapeutics, Inc.
56 patents
HOBART BROTHERS LLC
56 patents
HP PRINTING KOREA CO., LTD.
56 patents
INTEGRITY IMPLANTS INC.
56 patents
INVISAGE TECHNOLOGIES, INC.
56 patents
Insyde Software Corp.
56 patents
JCBD, LLC
56 patents
Johnson Controls Fire Protection LP
56 patents
INTERSURGICAL AG
56 patents
What this shows Intersurgical holds 56 patents at rank #6,035, shown against the 8 assignees closest to it in grant volume rather than the industry's largest filers.
By rank, the assignees closest to #6,035 in granted patent volume.
Other assignees with the most granted patents in Intersurgical's primary technology class.
Two PlainPatent-derived peer sets for Intersurgical, neither rank-band nor same-CPC leaders (those blocks stay above).
Nearest assignees by Innovation Score (36 here).
Nearest assignees by average claims per patent (7.9 here).
Intersurgical's Innovation Score vs. every tracked assignee
Composite of portfolio volume, grant velocity, technology breadth, and claim depth (0–100)
36 Top 47% higher than 53% of 50,000 US assignees
Each bar is a band; taller bars hold more US assignees. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count, share, and where it sits relative to this entry.
Source USPTO PatentsView, PlainPatent Innovation Score · 2015–2025
Teal-shaded recent years (2020–present) versus the 2015–2019 baseline. Full figures in the table below.
| Year | Patents Granted | Share of Period |
|---|---|---|
| 2015 | 9 | 16.1% |
| 2016 | 4 | 7.1% |
| 2017 | 6 | 10.7% |
| 2018 | 5 | 8.9% |
| 2019 | 8 | 14.3% |
| 2020 | 6 | 10.7% |
| 2021 | 8 | 14.3% |
| 2023 | 1 | 1.8% |
| 2024 | 7 | 12.5% |
| 2025partial year | 2 | 3.6% |
Top 15 of 18 technology areas
Overall rank by patents
#6,036
of 50,000 tracked assignees
36.1 out of 100
Every figure on PlainPatent is rendered directly from USPTO source data, no number is typed in by an editor. This page draws directly on USPTO source data, no figure is typed in by an editor. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error. Data current as of May 2026.